Evelo Biosciences EVLO

$ 0.32 -14.46%

Quarterly report 2023-Q3
added 11-09-2023

Evelo Biosciences Financial Statements 2011-2024 | EVLO

Annual Financial Statements Evelo Biosciences

	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	27 M	249 M	820 M	216 M	202 M	-	-	-	-	-	-	-
Shares	87.2 M	52.9 M	46.7 M	32 M	21.9 M	-	-	-	-	-	-	-
Historical Prices	0.31	4.71	17.6	5.87	8.98	-	-	-	-	-	-	-
Net Income	-115 M	-122 M	-93.7 M	-85.5 M	-56.9 M	-28 M	-13.3 M	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-108 M	-115 M	-91.9 M	-86.4 M	-58.1 M	-27.5 M	-13 M	-	-	-	-	-
Interest Expense	61 K	486 K	738 K	26 K	-406 K	-301 K	-	-	-	-	-	-
EBITDA	-106 M	-113 M	-89.9 M	-84.6 M	-56.2 M	-26.7 M	-12.5 M	-	-	-	-	-
Operating Expenses	108 M	115 M	91.9 M	86.4 M	58.1 M	-	-	-	-	-	-	-
General and Administrative Expenses	29.9 M	31.8 M	22.3 M	23.2 M	18.2 M	7.57 M	3.89 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Evelo Biosciences

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	17.4 M	5.58 M	111 M	5.54 M	5.4 M	3.79 M	53.6 M	53.6 M	53.4 M	53.4 M	51.3 M	47.5 M	46.2 M	32.6 M	32.3 M	32.2 M	32.1 M	32 M	31.9 M	31.8 M	31.7 M	19.6 M	3.92 M	3.88 M	3.78 M	3.73 M	3.65 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-12.4 M	-21.1 M	-25.3 M	-	-30.6 M	-30.6 M	-29.9 M	-	-33.7 M	-31.6 M	-28.2 M	-	-20.9 M	-20.7 M	-23 M	-22.6 M	-21.6 M	-20.9 M	-20.3 M	-15.4 M	-15.9 M	-15.1 M	-10.5 M	-8.14 M	-8.17 M	-6.36 M	-5.37 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-11.2 M	-19.6 M	-24.9 M	-	-29.1 M	-29.6 M	-28.7 M	-	-32.7 M	-27.7 M	-27.5 M	-	-20.2 M	-20.2 M	-23.3 M	-	-21.5 M	-21.4 M	-20.8 M	-	-16.5 M	-15.2 M	-10.4 M	-	-8.04 M	-6.22 M	-5.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-27 K	69 K	188 K	-	-615 K	209 K	20 K	-	159 K	151 K	162 K	-	39 K	140 K	466 K	-	-218 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-11 M	-19.2 M	-24.5 M	-	-28.6 M	-29.1 M	-28.2 M	-	-31 M	-27.2 M	-26.9 M	-	-19.7 M	-19.7 M	-22.8 M	-	-21 M	-21 M	-20.4 M	-	-16.2 M	-14.5 M	-9.84 M	-	-7.84 M	-6.02 M	-5.04 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	11.2 M	19.6 M	24.9 M	-	29.1 M	29.6 M	28.7 M	-	32.7 M	27.7 M	27.5 M	-	20.2 M	20.2 M	23.3 M	22.7 M	21.5 M	21.4 M	20.8 M	16 M	16.5 M	15.2 M	10.4 M	8.07 M	8.04 M	6.22 M	5.21 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	3.89 M	4.92 M	7.04 M	-	7.13 M	8.37 M	9.42 M	-	10.1 M	7 M	5.96 M	-	5.27 M	5.07 M	5.84 M	-	5.89 M	5.92 M	5.12 M	-	5.23 M	5.06 M	3.28 M	-	2.69 M	1.53 M	1.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency